NCT05638451 2024-06-05Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) PatientsZhujiang HospitalPhase 2 Unknown30 enrolled
NCT06220552 2024-01-24The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent GlioblastomaFifth Affiliated Hospital, Sun Yat-Sen UniversityPhase 2 Recruiting20 enrolled